Back to mobile site

Morgan Stanley Upgrades Teva Pharma (TEVA) to Overweight

November 5, 2018 3:48 AM EST Send to a Friend
(Updated - November 5, 2018 7:02 AM EST)(updated to add analyst comment)Morgan Stanley analyst David Risinger upgraded Teva Pharma (NYSE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login